Novavax, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $2.26B
Liabilities Breakdown FY2022
Total Liabilities: $2.89B
Asset Breakdown
Total Assets: $2.26B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.34B | 59.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $36.7M | 1.6% |
| Property, Plant & Equipment | $294.2M | 13.0% |
| Goodwill | $126.3M | 5.6% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $464.5M | 20.6% |
Liabilities Breakdown
Total Liabilities: $2.89B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $216.5M | 7.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.68B | 92.5% |